XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 1,052 $ 102,507,189 $ (110,259,087) $ (7,750,846)
Balance, shares at Dec. 31, 2023 10,519,933      
Changes in Stockholders' Equity (Deficit)        
Exercise of common stock warrants, inclusive of warrant reduction $ 6 1,223,994   1,224,000
Exercise of common stock warrants, inclusive of warrant reduction, shares 60,000      
Issuance of common stock, net of issuance costs $ 43 3,874,957   3,875,000
Issuance of common stock, net of issuance costs, shares 431,366      
Stock-based compensation expense   364,765   364,765
Net loss     (1,066,947) (1,066,947)
Balance at Mar. 31, 2024 $ 1,101 107,970,905 (111,326,034) (3,354,028)
Balance, shares at Mar. 31, 2024 11,011,299      
Balance at Dec. 31, 2024 $ 1,414 144,155,694 (134,849,462) 9,307,646
Balance, shares at Dec. 31, 2024 14,141,521      
Changes in Stockholders' Equity (Deficit)        
Issuance of common stock pursuant to Equity Distribution Agreement, net of issuance costs $ 9 502,925   502,934
Issuance of common stock pursuant to Equity Distribution Agreement, net of issuance costs, shares 94,710      
Issuance of common stock and warrants under registered direct offering, net of issuance costs $ 525 19,279,964   19,280,489
Issuance of common stock and warrants under registered direct offering, net of issuance costs, shares 5,250,000      
Stock-based compensation expense   499,887   499,887
Net loss     (5,537,069) (5,537,069)
Balance at Mar. 31, 2025 $ 1,948 $ 164,438,470 $ (140,386,531) $ 24,053,887
Balance, shares at Mar. 31, 2025 19,486,231